Therapeutic strategies in epithelial ovarian cancer

被引：0
作者：
Ayako Kim
Yutaka Ueda
Tetsuji Naka
Takayuki Enomoto
机构：
[1] Osaka University Graduate School of Medicine,Department of Obstetrics and Gynecology
[2] National Institute of Biomedical Innovation,Laboratory for Immune Signal
来源：
Journal of Experimental & Clinical Cancer Research | / 31卷
关键词：
Review; ovarian cancer; conventional treatment; novel treatment; clear cell carcinoma; bevacizumab; PARP inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Ovarian cancer is the most lethal gynecologic malignancy. It appears that the vast majority of what seem to be primary epithelial ovarian and primary peritoneal carcinomas is, in fact, secondary from the fimbria, the most distal part of the fallopian tube.
引用
收藏
相关论文
共 167 条
[51]  
Kigawa J(undefined)undefined undefined undefined undefined-undefined
[52]  
T Enomoto CK(undefined)undefined undefined undefined undefined-undefined
[53]  
Yamasaki M(undefined)undefined undefined undefined undefined-undefined
[54]  
Sugita N(undefined)undefined undefined undefined undefined-undefined
[55]  
Otsuki Y(undefined)undefined undefined undefined undefined-undefined
[56]  
Ikegami H(undefined)undefined undefined undefined undefined-undefined
[57]  
Matsuzaki N(undefined)undefined undefined undefined undefined-undefined
[58]  
Yamada T(undefined)undefined undefined undefined undefined-undefined
[59]  
Wakimoto A(undefined)undefined undefined undefined undefined-undefined
[60]  
Murata Y(undefined)undefined undefined undefined undefined-undefined
12345678910